Source: ALL
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.600 | limited | 0.955 | 66 | 1 | 2014 | 2020 | ||||||||
|
patatin like phospholipase domain containing 3 | 0.556 | 0.692 | 5.7E-08 |
|
disease | 0.500 | None | 0.977 | 220 | 15 | 2008 | 2020 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.400 | None | 0.928 | 69 | 7 | 2005 | 2020 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
disease | 0.400 | None | 0.979 | 48 | 3 | 2007 | 2020 | ||||||||
|
sirtuin 1 | 0.378 | 0.885 | 8.7E-02 |
|
disease | 0.400 | None | 1.000 | 42 | 2 | 2010 | 2020 | ||||||||
|
leptin | 0.349 | 0.846 | 0.46 |
|
disease | 0.400 | None | 1.000 | 35 | 0 | 2009 | 2020 | ||||||||
|
fibroblast growth factor 21 | 0.485 | 0.769 | 2.9E-02 |
|
disease | 0.400 | None | 1.000 | 30 | 0 | 2010 | 2019 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.400 | None | 1.000 | 15 | 0 | 2011 | 2020 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
disease | 0.400 | None | 1.000 | 12 | 0 | 2005 | 2019 | ||||||||
|
nuclear receptor subfamily 1 group H member 4 | 0.513 | 0.808 | 9.4E-04 |
|
disease | 0.400 | None | 1.000 | 12 | 0 | 2015 | 2019 | ||||||||
|
peroxisome proliferator activated receptor delta | 0.513 | 0.846 | 0.99 |
|
disease | 0.380 | None | 1.000 | 9 | 0 | 2006 | 2020 | ||||||||
|
sterol regulatory element binding transcription factor 1 | 0.518 | 0.808 | 1.5E-02 |
|
disease | 0.380 | None | 1.000 | 9 | 2 | 2013 | 2019 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
disease | 0.370 | None | 1.000 | 10 | 0 | 2009 | 2016 | ||||||||
|
X-box binding protein 1 | 0.477 | 0.846 | 3.2E-02 |
|
disease | 0.370 | None | 1.000 | 8 | 0 | 2009 | 2019 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
disease | 0.370 | None | 1.000 | 8 | 0 | 2007 | 2019 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.360 | None | 1.000 | 7 | 0 | 2011 | 2018 | ||||||||
|
glycine N-methyltransferase | 0.626 | 0.462 | 2.8E-03 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 2010 | 2019 | ||||||||
|
phosphatidylethanolamine N-methyltransferase | 0.653 | 0.538 | 0.23 |
|
disease | 0.340 | None | 1.000 | 5 | 1 | 2005 | 2019 | ||||||||
|
carnitine palmitoyltransferase 1A | 0.555 | 0.808 | 5.1E-09 |
|
disease | 0.340 | None | 1.000 | 5 | 0 | 2015 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.340 | None | 1.000 | 5 | 0 | 2003 | 2019 | ||||||||
|
nuclear receptor subfamily 5 group A member 2 | 0.563 | 0.731 | 0.24 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2016 | 2018 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2017 | 2020 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2011 | 2019 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2017 | 2019 | ||||||||
|
protein kinase C alpha | 0.440 | 0.846 | 0.37 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2018 | 2019 |